Saturday, September 23, 2023
Saturday, September 23, 2023

Christopher Holland Appointed Electromed Chief Commercial Officer – 30+Years of Experience

Christopher Holland, an accomplished sales and marketing veteran, brings 30 years of experience in driving commercial growth in the Medical Technology market to Electromed.

Prior to joining Electromed, Holland was the Vice President of Commercialization at Prosomnus Sleep Technologies, Inc., a Medical Device manufacturer of a mandibular advancement device for sleep apnea where he led new product introduction and revenue-growth initiatives across the enterprise.

Prior to his time at Prosomnus, Christopher Holland spent over a decade as the Chief Commercial Officer and Executive Vice President of Sales and Global Business Development at Nonin Medical, Inc., where his accomplishments included delivering record global sales by successfully initiating and leading a corporate commercial turnaround. Earlier in his career, Holland held various leadership roles at Cisco Systems and PriceWaterhouseCoopers.

“We are thrilled to welcome Christopher Holland to our team at an exciting time,” said Kathleen Skarvan, Chief Executive Officer. “The Chief Commercial Officer is a strategic and value-added role for Electromed that will strengthen marketing, sales strategy and execution in support of our revenue growth goals, ultimately enhancing shareholder value. After conducting a lengthy and diligent search, we are confident that Chris is the ideal person to lead these strategic efforts.”

“I am very excited to be joining the Electromed team,” said Mr. Holland. “I believe Electromed has a best-in-class product and a very talented management team, which uniquely positions the company for growth in an under-served market. I look forward to guiding the Company’s strategic growth initiatives, while optimizing return on investment, and am delighted to work closely with Kathleen and her team to bring Electromed to the forefront of the airway clearance market.”

 

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

MORE EXECUTIVES

Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer

Brian Schubmehl brings more than two decades of diverse and senior global leadership expertise that has spanned private equity, startup, and publicly traded organizations.

Joseph Schwab MD, MS, to Lead Spine-Oncology Program and Center for Surgical Technology and AI Research at Cedars-Sinai

Joseph Schwab combines extensive experience in translational research and clinical trials with a record of high-quality clinical care. He specializes in the management of benign and malignant bone tumors as well as spinal disorders, including stenoses and myelopathy. His expertise will drive transformative advancements in spine oncology and surgical technology at Cedars-Sinai.

Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing

Adam Hodges brings more than 20 years of commercialization experience in the medical device industry. Most recently, Adam was Vice President of Sales at SIA Health, leading the commercial acceleration of DuraSorb®, which was acquired by Integra LifeSciences (NASDAQ: IART) in December 2022. During his tenure at SIA, Adam grew sales revenue by more than 5X in less than two years and previously served concurrent roles of Vice President of Strategic Accounts and Regional Business Director.

By using this website you agree to accept Medical Device News Magazine Privacy Policy